New stent aims to dry up tears after eye surgery
NCT ID NCT03705000
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a redesigned lacrimal stent, called the Slit Stent II, for people with severe tearing (epiphora) caused by a blocked tear duct. The stent has slits to allow tears to drain while it is still in place after DCR surgery. The trial planned to enroll 5 people to check safety and symptom relief, but it was terminated early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Slit Stent II lacrimal stent (a modified medical device)
What this could lead to
If it works, this could offer a way to relieve severe tearing sooner after DCR surgery without compromising long-term results.
What could go wrong
This was a very small, early trial (only 5 participants planned) that was terminated, so results are limited. The device is a modification of an existing stent, and its safety and effectiveness are not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOLACRIMAL DUCT OBSTRUCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kellogg Eye Center, 1000 Wall Street
Ann Arbor, Michigan, 48105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Low-Dose eye drop stop constant watery eyes?
- Can a simple additive make eye surgery safer for the heart?
- Nasal splint may improve tear duct surgery success
- New combo therapy may offer relief for chronic watery eyes
- Action camera modified for nose exams – could it replace bulky equipment?
- Eye drops may shield tear ducts from radioactive iodine damage